Evidence map›Paper›PMID 27228093›Full record

Trial reportPloS one2016

Intestinal Microbiota Is Influenced by Gender and Body Mass Index.

Carmen Haro, Oriol A Rangel-Zúñiga, Juan F Alcalá-Díaz, Francisco Gómez-Delgado, Pablo Pérez-Martínez, Javier Delgado-Lista, Gracia M Quintana-Navarro, Blanca B Landa, Juan A Navas-Cortés, Manuel Tena-Sempere and 4 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03888742 (A Cross Sectional Study to Assess the Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate Cancer), which is not on this map. Cited by 375 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
375citing papers in PubMed, 11 pooled it
32.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03888742 completednot on this mapstarted 2018, after this paper: background citation

A Cross Sectional Study to Assess the Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate Cancer

TypeobservationalSponsorChinese University of Hong KongRan2018 to 2021Enrolled214ConditionsProstate Cancer
3 · Its place in the literature

Who cites it

375 citing papers in PubMed, 11 syntheses or guidelines pooled it, 690 citations in OpenAlex.

  1. Pooled it
  2. Gut Microbiota and Liver Health: Meta-Analysis ofInternational journal of molecular sciences · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Yak Gut Microbiota: A Systematic Review and Meta-Analysis.Frontiers in veterinary science · 2022
    Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Review

315 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Carmen HaroLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Oriol A Rangel-ZúñigaLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Juan F Alcalá-DíazLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Francisco Gómez-DelgadoLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Pablo Pérez-MartínezLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Javier Delgado-ListaLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Gracia M Quintana-NavarroLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Blanca B LandaInstituto de Agricultura Sostenible (IAS), Consejo Superior de Investigaciones Científicas (CSIC), Cordoba, Spain.
Juan A Navas-CortésInstituto de Agricultura Sostenible (IAS), Consejo Superior de Investigaciones Científicas (CSIC), Cordoba, Spain.
Manuel Tena-SempereCIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain.
José C ClementeDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States of America.
José López-MirandaLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Francisco Pérez-JiménezLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
Antonio CamargoLipids and Atherosclerosis Unit, GC9 Nutrigenomics. IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.ORCID 0000-0002-0415-4184
Instituto de Salud Carlos III · ESConsejo Superior de Investigaciones Científicas · ESIcahn School of Medicine at Mount Sinai · US

Funding

RESEARCH TRAININGP30DK026687 · NIDDK · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI Anthony W Ferrante, DYMPNA GALLAGHER · 1986 to 2026
$33.0M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK026687
6 · The paper itself

Abstract

Intestinal microbiota changes are associated with the development of obesity. However, studies in humans have generated conflicting results due to high inter-individual heterogeneity in terms of diet, age, and hormonal factors, and the largely unexplored influence of gender. In this work, we aimed to identify differential gut microbiota signatures associated with obesity, as a function of gender and changes in body mass index (BMI). Differences in the bacterial community structure were analyzed by 16S sequencing in 39 men and 36 post-menopausal women, who had similar dietary background, matched by age and stratified according to the BMI. We observed that the abundance of the Bacteroides genus was lower in men than in women (P<0.001, Q = 0.002) when BMI was > 33. In fact, the abundance of this genus decreased in men with an increase in BMI (P<0.001, Q<0.001). However, in women, it remained unchanged within the different ranges of BMI. We observed a higher presence of Veillonella (84.6% vs. 47.2%; X2 test P = 0.001, Q = 0.019) and Methanobrevibacter genera (84.6% vs. 47.2%; X2 test P = 0.002, Q = 0.026) in fecal samples in men compared to women. We also observed that the abundance of Bilophila was lower in men compared to women regardless of BMI (P = 0.002, Q = 0.041). Additionally, after correcting for age and sex, 66 bacterial taxa at the genus level were found to be associated with BMI and plasma lipids. Microbiota explained at P = 0.001, 31.17% variation in BMI, 29.04% in triglycerides, 33.70% in high-density lipoproteins, 46.86% in low-density lipoproteins, and 28.55% in total cholesterol. Our results suggest that gut microbiota may differ between men and women, and that these differences may be influenced by the grade of obesity. The divergence in gut microbiota observed between men and women might have a dominant role in the definition of gender differences in the prevalence of metabolic and intestinal inflammatory diseases.

Indexed as

BacteriaBody Mass IndexGastrointestinal MicrobiomeSex CharacteristicsAdultAge FactorsFemaleHumansLipidsMaleObesityLipids

Identifiers

PMID27228093
PMCPMC4881937
OpenAlexW2404939443

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.